Blueprint Medicines Cash from Investing (TTM) Analysis

Blueprint Medicines Corp (BPMC)

93.10 +0.10 (+0.11%) USD | NASDAQ | Apr 29, 16:00

93.04 -0.06 (-0.07%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	274.04M
September 30, 2023	141.99M
June 30, 2023	19.34M
March 31, 2023	64.34M
December 31, 2022	-149.54M
September 30, 2022	-443.21M
June 30, 2022	-206.90M
March 31, 2022	-399.15M
December 31, 2021	-225.86M
September 30, 2021	45.56M
June 30, 2021	-488.65M
March 31, 2021	-361.91M
December 31, 2020	-434.25M
September 30, 2020	-290.98M
June 30, 2020	213.69M
March 31, 2020	-45.92M
December 31, 2019	-16.47M
September 30, 2019	-27.96M
June 30, 2019	-85.91M

Date	Value
March 31, 2019	147.35M
December 31, 2018	-161.09M
September 30, 2018	-167.46M
June 30, 2018	-191.92M
March 31, 2018	-327.26M
December 31, 2017	-72.35M
September 30, 2017	-260.51M
June 30, 2017	-268.25M
March 31, 2017	-112.67M
December 31, 2016	-218.82M
September 30, 2016	-84.22M
June 30, 2016	-69.42M
March 31, 2016	-75.16M
December 31, 2015	-6.079M
September 30, 2015	-2.794M
June 30, 2015	-2.161M
March 31, 2015	-1.891M
December 31, 2014	-0.70M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-488.65M

Minimum

Jun 2021

274.04M

Maximum

Dec 2023

-127.25M

Average

-85.91M

Median

Jun 2019

Cash from Investing (TTM) Benchmarks